WMAS Board Meeting Agenda – Wednesday 25th March 2026

To request a copy of the full Board Papers for this meeting, please email [email protected]

Membership

  • Prof. I Cumming              Non-Executive Director (Chairman) and voting member
  • Mr AC Marsh                     Chief Executive Officer and voting member
  • Prof. A. Hopkins              Non-Executive Director (Deputy Chair) and voting member
  • Ms S Banks                        Non-Executive Director and voting member
  • Ms C Beechey                  Director of People and voting member
  • Mr A Brown                        Service Transformation and Patient Safety Director
  • Mrs C Eyre                         Director of Nursing and voting member
  • Mr M Fessal                       Non-Executive Director and voting member
  • Mr N Hudson                    Chief Operating Officer and voting member
  • Mrs J Jasper                       Non-Executive Director and voting member
  • Mr M Khan                          Non-Executive Director and voting member
  • Mr V Khashu                      Strategy and Engagement Director
  • Mr M MacGregor             Communications Director
  • Mr S Nat                              Non-Executive Director and voting member
  • Ms K Rutter                        Director of Finance and voting member
  • Dr R Steyn                          Medical Director and voting member

In attendance

  • Ms D Scott                         Organisational Assurance Director
  • Ms K Freeman                  Private Secretary, Office of the Chief Executive
  • Ms R Farrington               Staff Side Representative
  • Mr P. Higgins                     Governance Director and Trust Secretary

All attendees to this meeting must be aware that access may be given to all minutes and associated documents under the Freedom of Information Act 2000.

Item 1

Apologies and Chairman’s matters – lead by the Chair (Verbal)

Item 2

Declarations of Interest – lead by the Chair (Verbal)

To enable declarations to be made, of any conflict of interest members may have in relation to any matters contained within the agenda for this meeting

Item 3

Any questions received from the public prior to the meeting

Item 4

Board Minutes

To agree as a correct report the Minutes of the meeting of the Board of Directors held on 28 January 2026 as a correct record of that meeting – lead by the Chair (Paper 01)

Item 5

Action Log and any matters arising not on the agenda for this meeting

  1. Given that the impact of handover delays on the quality of patient care and safety is a consistent and recurring theme throughout the Minutes of the last meeting, and given the recent Channel 4 news item on the subject, this is to give notice that this will be raised under “ matters arising item from the last meeting“ at this meeting – lead by the Chairman/CEO (verbal)
  2. To review the Board Action Log and any matters arising from the Minutes and not on the agenda for this meeting – lead by the Organisational Assurance Director (Paper 02)

Item 6

Board Assurance Framework – lead by the Director of Nursing / Head of Risk (Paper 03)

Information:

Action – To receive and note the report

Item 7

Chief Executive Officer Reports – lead by the CEO (Paper 04a)

  1. CEO report
Information:

Action – To receive and note the report

b. Executive Scorecard – February 2026 Executive Scorecard ICS Sub Report – February 2026 – lead by the CEO (Paper 04b 1 and 2)

Information:

Action – To review and receive the Executive Scorecards

c. Five-year strategy update – lead by the CEO/Strategy and Engagement Director (Paper 04c)

Information:

Action
a)      For the Board to receive the draft organisational strategy alongside the feedback received from stakeholders.
b)      For the Board to receive the draft organisational strategy alongside the feedback received from stakeholders.

d. Provider Capability Assessment outcome and Quarterly Segmentation Outcome – lead by the CEO/Strategy and Engagement Director (verbal)

Action –

  1. To receive the Provider Capability Assessment outcome
  2. To receive the Quarterly Segmentation Outcome

Item 8

Reports of the Director of Finance – lead by the Director of Finance (Paper 05a)

  1. 2025/26 Month 11 finance report
Information:

Action
To note the reported results for the first 11 months of the 25/26 financial year for Revenue and Capital
To note the Balance Sheet, Service Line Reporting breakdown and the underlying financial position information included in the pack
To note the current risk with fuel supplies and pricing

b. 26/27 Opening Budgets for approval (Revenue and Capital) – (Paper 05b)

Information:

Action
The board is requested to:
Note the plan resubmission on 18 March 2026
Note the outstanding contract position
Approve the 26/27 opening budget in order that the Trust can continue to operate within an approved financial plan

c)    Finance Strategy – (Paper 05c)

Information:

 Action
The board is requested to:
Approve the Finance Strategy
Note the approvals governance in the progression from EMB to FPC then to the Board of Directors meeting in March

d)    Delegate to Audit Committee to approve the 2025/26 Annual Reports and Accounts – (Paper 05d)

Information:

Action
To approve a delegation of authority to the Audit Committee in relation to the approval of the 25/26 Annual Report and Accounts.

e)    Delegate to Director of Finance to sign the contracts with commissioners – (Paper 05e)

Information:

Action
To approve a delegation of authority to the Director of Finance in relation to the contract signature as required by NHS England and commissioning bodies.

Item 9

Reports of the Director of People – led by the Director of People (Papers 06a and 06b)

a) Board Skills Matrix 2025-2026

Information:

Action
Members of the Board of Directors are requested to consider and approve the content of the attached Board Skills Matrix for publication in the Trust’s Annual Report 2025 / 2026.

b) Staff Survey Results 2025 and 2026 Action Plan

Information:

Action
This report is for information only. No action is required.

Item 10

Combined Clinical Directors Quality Reports – lead by the Director of Nursing / The Medical Director / Service Transformation and Patient Safety Director (Paper 07)

Information:

Action
The Trust Board is asked to:
Receive and note the integrated quality report.
Gain assurance on the quality agenda and the robustness of the quality governance processes that highlight.
There remains the continued risks of patient harm being caused as the result of delayed responses, long handover delays and stacking calls in EOC.

Item 11

Report of the Chief Operating Officer – lead by the Chief Operating Officer (Paper 08)

Information:

Action
The board of directors are asked to:
a)            Accept and note the contents of this report.
b)            Discuss the risks outlined in this report from each service delivery line.

Item 12

Report of the Strategy and Engagement Director – lead by the Strategy and Engagement Director (Paper 09a, 9b and 9c)

Information:

Action
The Board of Directors is requested to: Review the following strategies and approve for their implementation
Fleet
Estates and Sustainability
Clinical and Quality

Also to review and accept the Impact Assessments in relation to the strategy

Item 13

Board Committee Meeting Minutes and Chair’s Report

  1. Audit Committee – led by the Chair of the Audit Committee (Paper 10a & b)
  1. To receive the Minutes of the Committee meeting held on 22 January 2026
  2. To receive the report of the Chair of the Committee on salient matters discussed at the meeting held on 10 March 2026

b. People Committee – led by the Chair of the People Committee (Paper 11 a & b)

  1. To receive the Minutes of the Committee meeting held on 8th December 2025
  2. To receive the report of the Chair of the Committee on salient matters discussed at the meeting held on 2nd February 2026.

c. Finance and Performance Committee – led by the Chair of the Finance and Performance Committee (Paper 12 a & b)

  1. To receive the Minutes of the Committee meeting held on 19th January 2026
  2. To receive a report form the Chair of the Committee on the salient matters and risks considered at the meeting held on 17th March 2026

d. Quality Governance Committee – led by the Chair of the Quality Governance Committee (Paper 13 a and B)

  1. To receive the Minutes of the Committee meeting held on 21th January 2026
  2. To receive a report from the Chair of the Committee on the salient matters and risks considered at the meeting held on 18th March 2026

Item 13

Board Schedule of Business – led by the Chairman (Paper 14)

Item 14

Any Other Business (previously notified to the Trust Secretary)

Item 15

Date and Time of the Next Meeting

The next meeting will be on Wednesday 27th May 2026

At the conclusion of the formal Board Meeting

Board to Review the meeting and identify any new or increased risks that have arisen.

Please note:

Timings are appropriate

Preferred means of contact for Any Other Business Items is via email to Trust Secretary Phil Higgins – [email protected]

Page last reviewed: